Cargando…

Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences

PURPOSE: To verify MR measurements of myocardial extracellular volume fraction (ECV) based on clinically applicable T1‐mapping sequences against ECV measurements by radioisotope tracer in pigs and to relate the results to those obtained in volunteers. METHODS: Between May 2016 and March 2017, 8 volu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordlund, David, Xanthis, Christos, Bidhult, Sebastian, Jablonowski, Robert, Kanski, Mikael, Kopic, Sascha, Carlsson, Marcus, Engblom, Henrik, Aletras, Anthony H., Arheden, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900009/
https://www.ncbi.nlm.nih.gov/pubmed/31418490
http://dx.doi.org/10.1002/mrm.27938
_version_ 1783477259633426432
author Nordlund, David
Xanthis, Christos
Bidhult, Sebastian
Jablonowski, Robert
Kanski, Mikael
Kopic, Sascha
Carlsson, Marcus
Engblom, Henrik
Aletras, Anthony H.
Arheden, Håkan
author_facet Nordlund, David
Xanthis, Christos
Bidhult, Sebastian
Jablonowski, Robert
Kanski, Mikael
Kopic, Sascha
Carlsson, Marcus
Engblom, Henrik
Aletras, Anthony H.
Arheden, Håkan
author_sort Nordlund, David
collection PubMed
description PURPOSE: To verify MR measurements of myocardial extracellular volume fraction (ECV) based on clinically applicable T1‐mapping sequences against ECV measurements by radioisotope tracer in pigs and to relate the results to those obtained in volunteers. METHODS: Between May 2016 and March 2017, 8 volunteers (25 ± 4 years, 3 female) and 8 pigs (4 female) underwent ECV assessment with SASHA, MOLLI5(3b)3, MOLLI5(3s)3, and MOLLI5s(3s)3s. Myocardial ECV was measured independently in pigs using a radioisotope tracer method. RESULTS: In pigs, ECV in normal myocardium was not different between radioisotope (average ± standard deviation; 19 ± 2%) and SASHA (21 ± 2%; P = 0.086). ECV was higher by MOLLI5(3b)3 (26 ± 2%), MOLLI5(3s)3 (25 ± 2%), and MOLLI5s(3s)3s (25 ± 2%) compared with SASHA or radioisotope (P ≤ 0.001 for all). ECV in volunteers was higher by MOLLI5(3b)3 (26 ± 3%) and MOLLI5(3s)3 (26 ± 3%) than by SASHA (22 ± 3%; P = 0.022 and P = 0.033). No difference was found between MOLLI5s(3s)3s (25 ± 3%) and SASHA (P = 0.225). Native T1 of blood and myocardium as well as postcontrast T1 of myocardium was consistently lower using MOLLI compared with SASHA. ECV increased over time as measured by MOLLI5(3b)3 and MOLLI5(3s)3 for pigs (0.08% and 0.07%/min; P = 0.004 and P = 0.013) and by MOLLI5s(3s)3s for volunteers (0.07%/min; P = 0.032) but did not increase as measured by SASHA. CONCLUSION: Clinically available MOLLI and SASHA techniques can be used to accurately estimate ECV in normal myocardium where MOLLI‐sequences show minor overestimation driven by underestimation of postcontrast T1 when compared with SASHA. The timing of imaging after contrast administration affected the measurement of ECV using some variants of the MOLLI sequence.
format Online
Article
Text
id pubmed-6900009
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69000092019-12-20 Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences Nordlund, David Xanthis, Christos Bidhult, Sebastian Jablonowski, Robert Kanski, Mikael Kopic, Sascha Carlsson, Marcus Engblom, Henrik Aletras, Anthony H. Arheden, Håkan Magn Reson Med Full Paper—Preclinical and Clinical Imaging PURPOSE: To verify MR measurements of myocardial extracellular volume fraction (ECV) based on clinically applicable T1‐mapping sequences against ECV measurements by radioisotope tracer in pigs and to relate the results to those obtained in volunteers. METHODS: Between May 2016 and March 2017, 8 volunteers (25 ± 4 years, 3 female) and 8 pigs (4 female) underwent ECV assessment with SASHA, MOLLI5(3b)3, MOLLI5(3s)3, and MOLLI5s(3s)3s. Myocardial ECV was measured independently in pigs using a radioisotope tracer method. RESULTS: In pigs, ECV in normal myocardium was not different between radioisotope (average ± standard deviation; 19 ± 2%) and SASHA (21 ± 2%; P = 0.086). ECV was higher by MOLLI5(3b)3 (26 ± 2%), MOLLI5(3s)3 (25 ± 2%), and MOLLI5s(3s)3s (25 ± 2%) compared with SASHA or radioisotope (P ≤ 0.001 for all). ECV in volunteers was higher by MOLLI5(3b)3 (26 ± 3%) and MOLLI5(3s)3 (26 ± 3%) than by SASHA (22 ± 3%; P = 0.022 and P = 0.033). No difference was found between MOLLI5s(3s)3s (25 ± 3%) and SASHA (P = 0.225). Native T1 of blood and myocardium as well as postcontrast T1 of myocardium was consistently lower using MOLLI compared with SASHA. ECV increased over time as measured by MOLLI5(3b)3 and MOLLI5(3s)3 for pigs (0.08% and 0.07%/min; P = 0.004 and P = 0.013) and by MOLLI5s(3s)3s for volunteers (0.07%/min; P = 0.032) but did not increase as measured by SASHA. CONCLUSION: Clinically available MOLLI and SASHA techniques can be used to accurately estimate ECV in normal myocardium where MOLLI‐sequences show minor overestimation driven by underestimation of postcontrast T1 when compared with SASHA. The timing of imaging after contrast administration affected the measurement of ECV using some variants of the MOLLI sequence. John Wiley and Sons Inc. 2019-08-16 2020-02 /pmc/articles/PMC6900009/ /pubmed/31418490 http://dx.doi.org/10.1002/mrm.27938 Text en © 2019 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Paper—Preclinical and Clinical Imaging
Nordlund, David
Xanthis, Christos
Bidhult, Sebastian
Jablonowski, Robert
Kanski, Mikael
Kopic, Sascha
Carlsson, Marcus
Engblom, Henrik
Aletras, Anthony H.
Arheden, Håkan
Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title_full Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title_fullStr Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title_full_unstemmed Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title_short Measuring extracellular volume fraction by MRI: First verification of values given by clinical sequences
title_sort measuring extracellular volume fraction by mri: first verification of values given by clinical sequences
topic Full Paper—Preclinical and Clinical Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900009/
https://www.ncbi.nlm.nih.gov/pubmed/31418490
http://dx.doi.org/10.1002/mrm.27938
work_keys_str_mv AT nordlunddavid measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT xanthischristos measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT bidhultsebastian measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT jablonowskirobert measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT kanskimikael measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT kopicsascha measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT carlssonmarcus measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT engblomhenrik measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT aletrasanthonyh measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences
AT arhedenhakan measuringextracellularvolumefractionbymrifirstverificationofvaluesgivenbyclinicalsequences